DAEZEL LACANLALE: Open Payments
NPI 1740765395 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$334 in 18 payments from 8 companies in 2025. Trend: 2023 $125 · 2024 $319 · 2025 $334
Food & beverage: $334
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $150 |
| Otsuka America Pharmaceutical, Inc. | 3 | $62 |
| Alkermes, Inc. | 1 | $27 |
| Gilead Sciences, Inc. | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| PFIZER INC. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Novo Nordisk Inc | 1 | $15 |
Products named: QULIPTA, UBRELVY, REXULTI, VIVITROL, GARDASIL 9, ABILIFY ASIMTUFII, NURTEC ODT, VRAYLAR.
Industry payments across VA — which companies pay providers there.
